Muhammad Furqan
Muhammad Furqan
Explore linked clinical trials.1 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Chemo-Immunotherapy Followed by Durvalumab and Ceralasertib in Treatment Naïve Patients With Extensive Stage Small Cell Lung Cancer | Extensive Stage Small Cell Lung Cancer | Active, not recruiting | Phase 2 | 2026-09-03 | NCT04699838 |